This is a non-core endpoint: only basic statistics are computed.
Degenerative and vascular disorders of ear
H8_DEGVASCEAR
auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
54 |
4. Check minimum number of eventsNone |
54 |
5. Include endpointsNone |
54 |
6. Filter based on genotype QC (FinnGen only) |
54 |
Control definitions (FinnGen only)
- Control exclude
- H8_OTHEREAR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H93
- Name in latin
- Morbositates degenerativae et vasculares auris
Similar endpoints
↥List of similar endpoints to
Degenerative and vascular disorders of ear
based on the number of shared cases.
Similar with more cases:
- Other disorders of ear
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 378 | 210 | 163 |
| Only index persons | 332 | 190 | 142 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 61.72 | 64.72 | 57.93 |
| Only index persons | 59.52 | 63.23 | 54.56 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 54 | 28 | 26 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 53.55 | 51.67 | 55.57 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
21
108
2.55
2.62
2.2
2.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
11
5.98
2.62
10.3
2.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
22
119
2.43
2.45
2.3
2.5
u/l
55.6
54.8
0.06
22
110
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
14
4.68
2.21
1.0
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
29
191
2.12
1.92
8.3
6.5
mmol/l
1.2
1.2
1.07
23
160
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
31
211
2.10
1.87
4.8
7.2
umol/l
10.9
10.1
0.25
31
201
(3002582) Erythrocytes [#/volume] in Urine
21
128
2.05
1.66
3.9
2.8
e6/l
9.9
45.6
0.68
16
95
(3024561) Albumin [Mass/volume] in Serum or Plasma
26
174
1.95
1.57
3.0
4.1
g/l
33.6
35.8
1.09
26
165
(3009542) Hematocrit [Volume Fraction] of Blood
45
373
2.24
1.54
23.4
15.3
%
41.2
40.5
0.38
34
286
(3032080) INR in Blood by Coagulation assay
23
150
1.93
1.48
9.2
7.8
inr
1.7
1.2
—
6
41
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
23
150
1.93
1.48
3.8
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
23
151
1.91
1.44
1.9
2.1
pmol/l
117.0
100.7
—
7
73
(3013707) Erythrocyte sedimentation rate by Westergren method
39
305
2.00
1.44
3.2
4.1
mm/h
16.4
12.7
0.55
34
276
(3002385) Erythrocyte distribution width [Ratio]
42
338
2.09
1.41
24.0
19.0
%
14.0
13.8
0.27
42
333
(3023520) Reticulocytes [#/volume] in Blood
0
37
0.00
1.40
0.0
4.2
—
66.1
—
0
26
(3022217) INR in Platelet poor plasma by Coagulation assay
11
55
2.26
1.39
14.7
25.3
—
1.5
—
0
7
(3018095) Leukocytes [#/volume] in Urine
23
153
1.88
1.37
4.6
3.3
e6/l
25.2
54.2
0.38
16
101
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
44
2.25
1.34
1.1
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
68
1.98
1.11
1.1
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
27
200
1.70
1.07
5.1
6.7
e9/l
0.6
0.6
0.28
22
179
(3006315) Basophils [#/volume] in Blood
27
200
1.70
1.07
5.1
6.9
e9/l
0.0
0.0
0.48
22
180
(3007853) Bacteria identified in Skin by Aerobe culture
9
48
2.05
1.07
1.3
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
31
239
1.70
1.06
9.9
13.5
e9/l
4.0
4.1
0.13
26
210
(42870588) Differential panel, method unspecified - Blood
19
128
1.75
1.05
5.2
6.5
—
—
—
0
0
(3013512) EKG study
17
111
1.78
1.04
4.9
3.6
—
—
—
0
0
(3012544) pH of Venous blood
7
36
2.08
1.01
1.3
4.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
28
0.00
1.01
0.0
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
27
2.37
0.97
24.2
4.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
8
42
2.06
0.94
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
29
2.20
0.92
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
23
169
1.63
0.91
3.7
3.3
ng/l
29.1
55.4
0.45
16
108
(3030467) Casts [#/volume] in Urine by Automated count
17
116
1.68
0.88
4.1
2.7
e6/l
0.1
0.3
0.71
12
80
(3002256) Pathology report gross observation
8
46
1.87
0.87
1.0
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
11
67
1.81
0.82
3.8
2.5
e6/l
1.3
1.8
—
6
32
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
44
385
1.77
0.82
7.2
5.2
mmol/mol
41.6
39.7
0.84
38
358
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
24
0.00
0.81
0.0
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
23
173
1.57
0.81
1.8
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
46
414
1.75
0.76
5.6
4.8
mmol/l
2.8
2.7
0.35
40
383
(3004588) Protein electrophoresis panel - Serum or Plasma
5
25
2.10
0.75
1.4
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
41
1.81
0.73
3.4
3.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
23
177
1.52
0.72
13.0
11.1
e9/l
0.0
0.0
0.50
18
151
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
42
1.76
0.71
2.0
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
15
105
1.59
0.70
5.7
4.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
31
256
1.50
0.68
2.8
3.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
29
1.80
0.65
1.4
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
8
50
1.70
0.65
4.1
2.2
umol/l
4.3
6.7
—
8
45
(3019550) Sodium [Moles/volume] in Serum or Plasma
46
416
1.71
0.64
24.0
15.7
mmol/l
139.8
139.7
0.08
46
398
(3023103) Potassium [Moles/volume] in Serum or Plasma
46
420
1.64
0.64
24.2
15.6
mmol/l
4.0
4.0
0.25
46
403
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
45
408
1.62
0.62
5.2
4.3
mmol/l
1.4
1.4
0.34
40
377
(3015736) pH of Urine
21
163
1.47
0.61
2.9
3.4
—
—
—
0
0
(3000492) Spirometry study
6
35
1.80
0.60
1.3
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
34
291
1.45
0.59
4.2
3.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
44
397
1.58
0.58
4.9
3.8
mmol/l
1.5
1.3
1.06
39
368
(36304419) Bacteria [Presence] in Urine
16
122
1.44
0.50
3.9
2.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
10
70
1.53
0.45
1.7
1.5
g/l
2.6
2.7
—
5
42
(4035726)
5
31
1.67
0.44
1.0
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
14
107
1.42
0.43
5.8
9.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
15
0.00
0.42
0.0
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
36
1.43
0.39
1.0
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
6
41
1.52
0.37
4.2
3.1
u/l
45.8
35.7
—
6
36
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
6
43
1.44
0.36
2.3
4.7
ug/l
12.9
7.4
—
6
37
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
52
1.40
0.33
1.1
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
31
277
1.28
0.32
4.3
4.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
7
56
1.29
0.31
1.7
2.4
g/l
2.8
2.4
—
7
51
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
41
1.24
0.22
1.0
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
16
137
1.24
0.22
2.7
2.7
ng/l
883.5
1180.0
0.34
11
122
(3039443) Prostate specific Ag panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.8
—
21.6
—
0
10
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
14
119
1.24
0.20
3.5
3.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
7
60
1.19
0.19
2.1
2.5
umol/l
11.3
12.9
—
7
54
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
19
173
1.15
0.13
3.6
3.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
18
164
1.15
0.11
3.4
3.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
47
1.07
0.10
3.2
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
48
1.05
0.09
3.0
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
67
1.05
0.08
1.3
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
86
1.06
0.07
2.8
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
13
119
1.12
0.06
4.7
3.4
mg/mmol
4.7
7.3
—
8
74
(1761868) Lipid panel - Serum or Plasma
18
170
1.09
0.05
3.8
2.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11
104
1.07
0.01
3.2
3.7
%
14.7
22.7
—
5
48
(3015377) Calcium [Moles/volume] in Serum or Plasma
15
144
1.06
0.01
2.3
3.5
mmol/l
2.4
2.4
—
10
129
(3026008) Bacteria identified in Urine by Culture
13
127
1.03
0.00
2.8
2.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
11
108
1.02
0.00
3.6
2.7
mg/l
55.3
40.8
—
6
69
(3011397) Hemoglobin [Presence] in Urine by Test strip
10
102
0.98
0.00
2.9
3.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
30.0
—
0
7
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
4.2
—
0
8
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
8
0.00
0.00
0.0
3.1
—
62.5
—
0
8
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
7
0.00
0.00
0.0
1.1
—
242.1
—
0
7
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
50
1.00
0.00
2.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
6.7
—
176.3
—
0
7
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3042936) Bacteria identified in Isolate by Culture
6
61
0.98
0.00
2.0
2.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
6
0.00
0.00
0.0
2.8
—
31.8
—
0
6
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44790048)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
9
95
0.94
0.00
1.2
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
5
52
0.96
0.00
3.2
1.9
ug/g
274.4
97.0
—
5
44
(40760892) CBC W Ordered Manual Differential panel - Blood
9
98
0.90
0.00
2.9
6.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
0
5
0.00
0.00
0.0
3.2
—
84.8
—
0
5
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
59
1.02
0.00
3.7
1.9
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
9.8
—
0
5
(44790047)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790049)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806118)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
6.2
—
0
6
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_DEGVASCEAR and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have H8_DEGVASCEAR.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: H8_DEGVASCEAR – Degenerative and vascular disorders of ear
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data